Morimoto Mai Department
Hyogo Medical University(Specialty Division)
Clinical Laboratory Medicine, Clinical Medicine Seminars
Position
■ Presentation
1.
Systemic Immune-inflammation index in rheumatoid arthritis patients:relation to disease activity. (Poster presentation,General Lecture) 2019/06/13
2.
The baseline soluble GP130 is associated with the response of rheumatoid arthritis patients to sarilmab. (Poster presentation,General Lecture) 2020/07/03
3.
Increased levels of serum wisteria floribunda agglutininpositive Mac-2 binding protein in rheumatic diseases including SLE. (Newspaper announcement) 2021/06/02
4.
Successful treatment of checkpoint inhibitor-induced arthritis with the IL-6 receptor inhibitor Sarilumab. (Poster presentation,General Lecture) 2021/08/28
5.
Neutrophil count reduction 1month after initiating sarilumab and baseline serum soluble gp130 levels can independently predict clinical remission within 3 month in rheumatoid arthritis patients. (Newspaper announcement) 2022/06/01
6.
The baseline serum soluble TNF receptor level are associated with the response of rheumatoid arthritis
patients to JAKinibs. (Newspaper announcement) 2022/06/01
7.
Continued positivity in serum MMP-3 after normalization of CRP predicts future joint destruction in rheumatoid arthritis patients treated with MTX (Poster presentation,General Lecture) 2022/10/09
8.
Thyroid-stimulating antibody as an indicator of Graves' orbitopathy (Poster presentation,General Lecture) 2022/10/09